Prenetics Global Limited
PRE
$9.00
-$0.26-2.81%
NASDAQ
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 8.16% | -25.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.16% | -25.07% | |||
| Cost of Revenue | -16.82% | -6.87% | |||
| Gross Profit | 56.84% | -45.73% | |||
| SG&A Expenses | -22.79% | -25.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 319.97% | -49.75% | |||
| Total Operating Expenses | -3.48% | -16.57% | |||
| Operating Income | 7.87% | 12.84% | |||
| Income Before Tax | -22.01% | 34.99% | |||
| Income Tax Expenses | 193.04% | 84.03% | |||
| Earnings from Continuing Operations | -22.22% | 34.80% | |||
| Earnings from Discontinued Operations | -36.86% | 45.23% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 11.43% | 27.53% | |||
| Net Income | -24.88% | 37.77% | |||
| EBIT | 7.87% | 12.84% | |||
| EBITDA | 13.33% | 13.24% | |||
| EPS Basic | -21.05% | 43.84% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -26.23% | 43.79% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 3.16% | 10.81% | |||
| Average Diluted Shares Outstanding | 3.16% | 10.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||